232 related articles for article (PubMed ID: 15940616)
21. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH
Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128
[TBL] [Abstract][Full Text] [Related]
22. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
Kennedy NA; Kalla R; Warner B; Gambles CJ; Musy R; Reynolds S; Dattani R; Nayee H; Felwick R; Harris R; Marriott S; Senanayake SM; Lamb CA; Al-Hilou H; Gaya DR; Irving PM; Mansfield J; Parkes M; Ahmad T; Cummings JR; Arnott ID; Satsangi J; Lobo AJ; Smith M; Lindsay JO; Lees CW
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1313-23. PubMed ID: 25284134
[TBL] [Abstract][Full Text] [Related]
23. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
24. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
25. Relapse rate following azathioprine withdrawal in maintaining remission for Crohn's disease: a meta-analysis.
French H; Mark Dalzell A; Srinivasan R; El-Matary W
Dig Dis Sci; 2011 Jul; 56(7):1929-36. PubMed ID: 21476031
[TBL] [Abstract][Full Text] [Related]
26. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL
Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144
[TBL] [Abstract][Full Text] [Related]
27. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
[TBL] [Abstract][Full Text] [Related]
28. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.
Monteleone G; Neurath MF; Ardizzone S; Di Sabatino A; Fantini MC; Castiglione F; Scribano ML; Armuzzi A; Caprioli F; Sturniolo GC; Rogai F; Vecchi M; Atreya R; Bossa F; Onali S; Fichera M; Corazza GR; Biancone L; Savarino V; Pica R; Orlando A; Pallone F
N Engl J Med; 2015 Mar; 372(12):1104-13. PubMed ID: 25785968
[TBL] [Abstract][Full Text] [Related]
29. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Van Assche G; Magdelaine-Beuzelin C; D'Haens G; Baert F; Noman M; Vermeire S; Ternant D; Watier H; Paintaud G; Rutgeerts P
Gastroenterology; 2008 Jun; 134(7):1861-8. PubMed ID: 18440315
[TBL] [Abstract][Full Text] [Related]
30. Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
Iborra M; Herreras J; Boscá-Watts MM; Cortés X; Trejo G; Cerrillo E; Hervás D; Mínguez M; Beltrán B; Nos P
Dig Dis Sci; 2019 Jun; 64(6):1612-1621. PubMed ID: 30604371
[TBL] [Abstract][Full Text] [Related]
31. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
[TBL] [Abstract][Full Text] [Related]
32. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
Fraser AG; Orchard TR; Jewell DP
Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
[TBL] [Abstract][Full Text] [Related]
34. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
[TBL] [Abstract][Full Text] [Related]
35. Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.
Matsumoto T; Motoya S; Watanabe K; Hisamatsu T; Nakase H; Yoshimura N; Ishida T; Kato S; Nakagawa T; Esaki M; Nagahori M; Matsui T; Naito Y; Kanai T; Suzuki Y; Nojima M; Watanabe M; Hibi T;
J Crohns Colitis; 2016 Nov; 10(11):1259-1266. PubMed ID: 27566367
[TBL] [Abstract][Full Text] [Related]
36. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
[TBL] [Abstract][Full Text] [Related]
37. Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
[TBL] [Abstract][Full Text] [Related]
38. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
39. Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?
Campbell S; Ghosh S
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1073-6. PubMed ID: 11564958
[TBL] [Abstract][Full Text] [Related]
40. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
